| Literature DB >> 22776158 |
Ananda B Venkatachalam1, Santosh P Lall, Eileen M Denovan-Wright, Jonathan M Wright.
Abstract
BACKGROUND: Force, Lynch and Conery proposed the duplication-degeneration-complementation (DDC) model in which partitioning of ancestral functions (subfunctionalization) and acquisition of novel functions (neofunctionalization) were the two primary mechanisms for the retention of duplicated genes. The DDC model was tested by analyzing the transcriptional induction of the duplicated fatty acid-binding protein (fabp) genes by clofibrate in zebrafish. Clofibrate is a specific ligand of the peroxisome proliferator-activated receptor (PPAR); it activates PPAR which then binds to a peroxisome proliferator response element (PPRE) to induce the transcriptional initiation of genes primarily involved in lipid homeostasis. Zebrafish was chosen as our model organism as it has many duplicated genes owing to a whole genome duplication (WGD) event that occurred ~230-400 million years ago in the teleost fish lineage. We assayed the steady-state levels of fabp mRNA and heterogeneous nuclear RNA (hnRNA) transcripts in liver, intestine, muscle, brain and heart for four sets of duplicated fabp genes, fabp1a/fabp1b.1/fabp1b.2, fabp7a/fabp7b, fabp10a/fabp10b and fabp11a/fabp11b in zebrafish fed different concentrations of clofibrate. RESULT: Electron microscopy showed an increase in the number of peroxisomes and mitochondria in liver and heart, respectively, in zebrafish fed clofibrate. Clofibrate also increased the steady-state level of acox1 mRNA and hnRNA transcripts in different tissues, a gene with a functional PPRE. These results demonstrate that zebrafish is responsive to clofibrate, unlike some other fishes. The levels of fabp mRNA and hnRNA transcripts for the four sets of duplicated fabp genes was determined by reverse transcription, quantitative polymerase chain reaction (RT-qPCR). The level of hnRNA coded by a gene is an indirect estimate of the rate of transcriptional initiation of that gene. Clofibrate increased the steady-state level of fabp mRNAs and hnRNAs for both the duplicated copies of fabp1a/fabp1b.1, and fabp7a/fabp7b, but in different tissues. Clofibrate also increased the steady-state level of fabp10a and fabp11a mRNAs and hnRNAs in liver, but not for fabp10b and fabp11b.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22776158 PMCID: PMC3483278 DOI: 10.1186/1471-2148-12-112
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Figure 1 Electron micrographs of hepatocytes of zebrafish after clofibrate treatment. Staining of peroxisomes in the hepatocytes of zebrafish fed 0% clofibrate (A) and 1.00% clofibrate (B). Number of peroxisome per field of view in liver increased with increasing concentration of clofibrate fed zebrafish (C). Arrows point to peroxisomes. Bar = 2 μm.
Figure 2 Electron micrographs of heart cells of zebrafish after clofibrate treatment. Mitochondria in the heart cells of zebrafish fed 0% clofibrate (A) and 1.00% clofibrate (B). Number of mitochondria per field of view in heart increased with increasing concentration of clofibrate fed zebrafish (C). Bar = 2 μm.
Figure 3 The steady-state level of mRNA and hnRNA in various tissues of zebrafish fed clofibrate. The level of mRNA and hnRNA of the acox1 gene in liver (A, F), intestine (B, G), muscle (C, H), heart (D, I) and brain (E, J) was determined by RT-qPCR using gene-specific primers. The steady-state level of acox1 transcripts was normalized to the steady-state level of rpl13α transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (p < 0.05) in the relative steady-state level of acox1 mRNA and hnRNA between zebrafish [n = 12, (male = 6, female = 6)] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.
Figure 4 The steady-state level of mRNA and hnRNA in intestine (A, B, C, D), muscle (E, F, G, H) and heart (I, J, K, L) of zebrafish fed clofibrate. The level of mRNA and hnRNA was determined by RT-qPCR using gene-specific primers. The steady-state level of fabp transcripts was normalized to the steady-state level of rpl13α transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (p < 0.05) in the relative steady-state level of fabp mRNAs between zebrafish [n = 12, (male = 6, female = 6)] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.
Figure 5 The steady-state level of mRNA and hnRNA in liver (A, B, C), intestine (D, E, F) and muscle (G, H, I) of zebrafish fed clofibrate. The level of mRNA and hnRNA was determined by RT-qPCR using gene-specific primers. The steady-state level of fabp transcripts was normalized to the steady-state level of rpl13α transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (p < 0.05) in the relative steady-state level of fabp mRNAs between zebrafish [n = 12, (male = 6, female = 6)] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.
Figure 6 The steady-state level of mRNA and hnRNA in liver (A, B, C) and (mRNA and hnRNA) in liver (D, E, F) of zebrafish fed clofibrate. The level of mRNA and hnRNA was determined by RT-qPCR using gene-specific primers. The steady-state level of fabp transcripts was normalized to the steady-state level of rpl13α transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (p < 0.05) in the relative steady-state level of fabp mRNAs between zebrafish [n = 12, (male = 6, female = 6)] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.
Steady-state levels of specific mRNA and hnRNA of genes increased in tissues of zebrafish after clofibrate treatment
+, increase relative to control.
-, no change relative to control.
Composition of diets (% by weight)
| Vitamin free caseina | 33 | 33 | 33 | 33 | 33 |
| Wheat glutenb | 10 | 10 | 10 | 10 | 10 |
| Gelatina | 4 | 4 | 4 | 4 | 4 |
| Corn oilc | 4 | 4 | 4 | 4 | 4 |
| Fish oild | 4 | 4 | 4 | 4 | 4 |
| Corn starche | 33 | 33 | 33 | 33 | 33 |
| Celufil1 | 8.00 | 7.75 | 7.50 | 7.25 | 7.00 |
| Vitamin mixf | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 |
| Mineral mixg | 1 | 1 | 1 | 1 | 1 |
| Betaineh | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| DL-Methioninea | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Clofibratei | 0 | 0.25 | 0.50 | 0.75 | 1.00 |
| Total | 100 | 100 | 100 | 100 | 100 |
a US Biochemical. (Cleveland, OH, USA).
b Dover Mills Ltd. (Halifax, NS, Canada).
c Sobeys Inc. (Halifax, NS, Canada).
d Corey Feeds Ltd. (Fredericton, NB, Canada).
e National Starch and Chemical Co. (Bridgewater, NJ, USA).
f Vitamin added to supply the following (per kg diet): vitamin A, 8000 IU; vitamin D3, 4000 IU; vitamin E, 300 IU; menadione sodium bisulfite, 40 mg; Thiamine HCl, 50 mg; riboflavin, 70 mg; d-Ca pantothenate, 200 mg; biotin, 1.5 mg; folic acid, 20 mg; vitamin B12, 0.15 mg; niacin, 300 mg; pyridoxine HCl, 20 mg; ascorbic acid, 300 mg; inositol, 400 mg; choline chloride, 2000 mg; butylated hydroxy toluene, 15 mg; butylated hydroxy anisole, 15 mg.
g Mineral added to supply the following (per kg diet): manganous sulphate (32.5% Mn), 40 mg; ferrous sulphate (20.1% Fe), 30 mg; copper sulphate (25.4% Cu), 5 mg; zinc sulphate (22.7% Zn), 75 mg; sodium selenite (45.6% Se), 1 mg; cobalt chloride (24.8% Co), 2.5 mg; sodiumfluoride (42.5% F), 4 mg.
h Betaine anhydrous (96% feed grade). (Finnfeeds, Finland). i Sigma-Aldrich Inc. (St. Louis, MO, USA).
Primer sequences used for RT-qPCR
| mRNA quantification | ||||
| 791610 | TAAGCTGACAGCGTTTGTGAAGGG | AGATGCGTCTGCTGATCCTCTTGT | 60.0 | |
| 554095 | AAGCTGAAGGTGGTGCTGAACA | CACGTTTGCTGATGCGCTTGTA | 59.0 | |
| EB880179 | TGCCGTTCTCTGGGAAGTTTGAGT | TGACTTTGTCTCCGCTCAGCATCT | 61.0 | |
| 58128 | TGTGCCACTTGGAAACTGGTTGAC | AACATTGCCTACTTGCCTGGTAGG | 60.0 | |
| 407736 | AAACCACTGCTGATGACCGACACT | AGTGGTCTCTTTCCCATCCCACTT | 61.0 | |
| 171481 | TTACGCTCAGGAGAACTACG | CTTCCTGATCATGGTGGTTC | 55.0 | |
| 795210 | CGGCTCCAGAGCACTACATC | GTTCACTCATGTGCGGGAGC | 60.0 | |
| 447944 | TGTGCAGAAACAGACCTGGGA | ACAGCCACCACATCACCCATCTT | 60.0 | |
| 553579 | GCTGTCACTACATTCAAGACCTG | AGTTTACCATCCGCAAGGCTCA | 60.0 | |
| 449662 | AGTCAGCACGAGCTCTCTCC | GCCCTACAAAGTGAAAGGCA | 58.0 | |
| 560828 | AGCAAGTGCTGTTGGGCCAC | GTGTGGCGGTGATGGCCTGG | 61.0 | |
| hnRNA quantification | ||||
| 791610 | ATCAATGGAGGTCAACGGCGAC | CAGCATGCGTGAAGCCGCCC | 62.5 | |
| 554095 | GAACTAACGTGTGCTGCTTGTG | CACGTTTGCTGATGCGCTTGTA | 57.0 | |
| 58128 | CCATCCATCAGATTTCTATGTGGG | CATTATGCCTTCTCGTATGTGCG | 56.5 | |
| 407736 | TTGGAAATGTGACCAAACCGACGC | TCGTCTCGAAAGGGAATGCAGTGT | 61.5 | |
| 171481 | TCCAGCAGAACGGCAGCGAC | CGCCTGTAAAGTGAAGCCATTTCCA | 61.0 | |
| 447944 | CCAAGCCGTTTTTGATGATGTGAG | GCTATTAATTTCCCATCCGACACC | 57.0 | |
| 449662 | GGCTACTCCCGCTGCAGCAG | GGCCTGAGGGTTGTTGGGCC | 63.0 | |
| 560828 | ACCAACCCTTCCCGTGGACCA | AGCCAATGCTTGCTTCTACAACAGA | 61.5 | |
aAT, annealing temperature (°C).